At the time I first broke the story in November 2023, Dr. Paul Gregory St. Claire, 72, who was an anesthesiologist at Sparrow ...

A key rival could be Johnson & Johnson's recently-approved Invega Hafyera (paliperidone ... Since then, newer new drugs Austedo (deutetrabenazine) for Huntington's disease and migraine therapy ...

On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus ...

Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...

Second place was Johnson & Johnson’s schizophrenia treatment Invega Sustenna/Invega Trinza ... 10.7% net – which added $203 million to US drug spending. The biggest price increases were ...

Rising awareness, innovative therapies, and evolving treatment options drive this growth.

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

Renewed interest in psychedelics as treatments for mental disorders has recently emerged, but substantial challenges remain in obtaining evidence from available data to inform clinical decision ...

After hours: January 27 at 5:58:08 PM EST Loading Chart for DRUG ...